Relapses in Multiple Sclerosis: Definition, Pathophysiology, Features, Imitators, and Treatment

Article Properties
Cite
Sevim, Serhan. “Relapses in Multiple Sclerosis: Definition, Pathophysiology, Features, Imitators, and Treatment”. Turkish Journal Of Neurology, vol. 22, no. 3, 2016, pp. 99-108, https://doi.org/10.4274/tnd.75318.
Sevim, S. (2016). Relapses in Multiple Sclerosis: Definition, Pathophysiology, Features, Imitators, and Treatment. Turkish Journal Of Neurology, 22(3), 99-108. https://doi.org/10.4274/tnd.75318
Sevim, Serhan. “Relapses in Multiple Sclerosis: Definition, Pathophysiology, Features, Imitators, and Treatment”. Turkish Journal Of Neurology 22, no. 3 (2016): 99-108. https://doi.org/10.4274/tnd.75318.
Sevim S. Relapses in Multiple Sclerosis: Definition, Pathophysiology, Features, Imitators, and Treatment. Turkish Journal Of Neurology. 2016;22(3):99-108.
Journal Category
Medicine
Internal medicine
Neurosciences
Biological psychiatry
Neuropsychiatry
Neurology
Diseases of the nervous system
Citations
Title Journal Journal Categories Citations Publication Date
The effect of COVID-19 on Multiple Sclerosis relapse: A systematic review and meta-analysis Multiple Sclerosis and Related Disorders
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system
 2024
Alpha Calcitonin Gene-related Peptide, Neuropeptide Y, and Substance P as Biomarkers for Diagnosis and Disease Activity and Severity in Multiple Sclerosis

 CNS & Neurological Disorders - Drug Targets
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system
  • Medicine: Public aspects of medicine: Toxicology. Poisons
 2024
The effect of self-acupressure on quality of life, physical and cognitive function in relapsing remitting multiple sclerosis patients: A randomized controlled study EXPLORE
  • Medicine: Other systems of medicine
  • Medicine: Medicine (General): Medical technology
  • Medicine: Medicine (General)
 1 2023
Medication adherence to disease-modifying therapies among a cohort of Jordanian patients with relapsing-remitting multiple sclerosis: a multicentre cross-sectional study

 International Journal of Pharmacy Practice
  • Medicine: Therapeutics. Pharmacology
 2023
Predictors of severity and outcome of multiple sclerosis relapses

 BMC Neurology
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
 5 2023
Citations Analysis
Category Category Repetition
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system4
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry4
Medicine: Therapeutics. Pharmacology2
Medicine: Medicine (General)2
Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy1
Medicine: Other systems of medicine1
Medicine: Medicine (General): Medical technology1
Technology: Home economics: Nutrition. Foods and food supply1
Medicine: Public aspects of medicine: Toxicology. Poisons1
The category Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system 4 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Repository corticotropin injection in multiple sclerosis: an update and was published in 2018. The most recent citation comes from a 2024 study titled The effect of COVID-19 on Multiple Sclerosis relapse: A systematic review and meta-analysis. This article reached its peak citation in 2023, with 3 citations. It has been cited in 13 different journals, 15% of which are open access. Among related journals, the Arşiv Kaynak Tarama Dergisi cited this research the most, with 2 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year